![]() ![]() Opera doesn't get as much attention as the big three. You need to activate this application using licensed Email/Activation Code. Arcsoft Portrait Plus is one of the most popular and award winning photo. If there is a need to reconsider drugs not initially approved through the drug review process, the Ministry of Health has a process where drugs not listed through the CEDAC and ECDET review processes may be reconsidered for coverage, known as product listing agreements.Ambify 1.6.3 Sync streaming music to Philips Hue light bulbs. The Minister of Health makes the final decisions on the changes to the Alberta Drug Benefit List based on a number of considerations, including recommendations from CEDAC or ECDET. a listing recommendation made by the Canadian Expert Drug Advisory Committee (CEDAC)Īlberta's Expert Committee on Drug Evaluation and Therapeutics (ECDET) also reviews drug products and provides advice and recommendations to the Minister of Health concerning the therapeutic value and cost-effectiveness of the drugs.a systematic review of the available clinical evidence and a review of the pharmaco-economic evaluation, and.The Common Drug Review (CDR) is a single process for reviewing new drugs and providing listing recommendations to participating publicly funded drug benefit plans in Canada. Drug review processĪlberta's drug review process is described in detail in Section 1 of the Alberta Drug Benefit List.Īlberta is a participant in the national Common Drug Review. Get more information about these drug groupings and MAC pricing on the Alberta Blue Cross website. drugs used for treating cardiovascular disease such as high blood pressure, known as angiotensin converting enzyme (ACE) inhibitors and calcium channel blockers.drugs used for treating elevated cholesterol levels, known as statins or HMG-CoA reductase inhibitors.drugs used for treating ulcers or reflux disease by lowering stomach acid, known as proton pump inhibitors.drugs used for correcting electrolyte imbalances, known as potassium chloride tablets or liquids.drugs used for treating inflammation, known as nonsteroidal anti-inflammatory drugs or NSAIDS.Evidence-based decisions are made to select the drug groupings subject to MAC pricing. The maximum allowable cost (MAC) is the maximum amount Alberta’s supplementary health plans will pay for a specific drug product within a grouping of therapeutically equivalent drug products, and are subject to MAC pricing. Beneficiaries who choose higher cost alternatives are responsible for paying the difference in price. Generic drugs have the same therapeutic effectiveness as the other drug products in the interchangeable grouping.Īlberta's supplementary health plans will pay for the lowest priced drug product where interchangeable products can be used to fill a prescription. The least cost alternative price is the lowest cost medication in an interchangeable (generic) drug grouping. Drug price policies Least cost alternative ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |